Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Sublingual Film for Agitation in Delirium
NCT04382170Phase 2Withdrawn
- Start
- Jun 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of dexmedetomidine in agitation, delirium. Planned start Jun 2020; status: withdrawn.
02
Drugs
dexmedetomidine
03
Conditions
agitationdelirium
Beyond the preview
Go deeper on NCT04382170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04382170.